Vanguard Group Inc Repare Therapeutics Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 55,097 shares of RPTX stock, worth $154,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,097

Previous 55,545 0.81%

Holding current value

$154,822

Previous $183,000 3.28%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$2.75 - $3.99 $1,232 - $1,787	-448 Reduced 0.81%	55,097 $189,000
Q2 2024 Aug 13, 2024	SELL	$3.02 - $4.7 $893 - $1,391	-296 Reduced 0.53%	55,545 $183,000
Q1 2024 May 10, 2024	SELL	$4.53 - $8.41 $30,885 - $57,339	-6,818 Reduced 10.88%	55,841 $263,000
Q4 2023 Feb 14, 2024	SELL	$3.22 - $11.79 $39,937 - $146,231	-12,403 Reduced 16.52%	62,659 $457,000
Q3 2023 Nov 14, 2023	BUY	$8.16 - $13.01 $4,080 - $6,505	500 Added 0.67%	75,062 $906,000
Q2 2023 Aug 14, 2023	SELL	$8.63 - $12.53 $4,660 - $6,766	-540 Reduced 0.72%	74,562 $788,000
Q4 2022 Feb 10, 2023	BUY	$12.5 - $18.13 $15,750 - $22,843	1,260 Added 1.71%	75,102 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$11.57 - $15.59 $6,942 - $9,354	600 Added 0.82%	73,842 $895,000
Q2 2022 Aug 12, 2022	BUY	$8.45 - $14.84 $74,131 - $130,191	8,773 Added 13.61%	73,242 $1.02 Million
Q1 2022 May 13, 2022	BUY	$11.38 - $21.88 $4,096 - $7,876	360 Added 0.56%	64,469 $918,000
Q4 2021 Feb 14, 2022	BUY	$19.66 - $28.11 $571,417 - $817,017	29,065 Added 82.94%	64,109 $1.35 Million
Q3 2021 Nov 12, 2021	BUY	$25.71 - $35.24 $32,651 - $44,754	1,270 Added 3.76%	35,044 $920,000
Q2 2021 Aug 13, 2021	BUY	$30.1 - $34.85 $1.02 Million - $1.18 Million	33,774 New	33,774 $1.05 Million

Others Institutions Holding RPTX

# of Institutions

Shares Held

35.4M

Call Options Held

50K

Put Options Held

300

View Full List

About Repare Therapeutics Inc.

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $118M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

More about RPTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Repare Therapeutics Inc. Transaction History